Clinical trial
Dissecting Human Immune Responses To Infection With Influenza or SARS-CoV-2
NCT06848309 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dissecting Human Immune Responses To Infection With Influenza or SARS-CoV-2
- Lead sponsor
- Washington University School of Medicine
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 7, 2025
- Completion date
- October 31, 2029
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
immune response of host, influenza, sars-cov-2 (covid-19) infection